Description
Apixa Q Tablets 2.5mg are a vital direct oral anticoagulant (DOAC) containing Apixaban, a highly effective Factor Xa inhibitor. This medication plays a crucial role in preventing and managing various serious blood clotting conditions. At the 2.5mg strength, Apixa Q is specifically prescribed for the prevention of venous thromboembolism (VTE) following elective hip or knee replacement surgery, significantly reducing the risk of blood clots in the legs and lungs during the recovery period. It is also used to reduce the risk of stroke and systemic embolism in certain patients with non-valvular atrial fibrillation (NVAF) who meet specific clinical criteria (e.g., advanced age, low body weight, or impaired kidney function), offering a tailored approach to anticoagulation. Furthermore, Apixa Q 2.5mg may be indicated for the prevention of recurrent deep vein thrombosis (DVT) and pulmonary embolism (PE) after initial treatment. As a powerful anticoagulant, Apixa Q 2.5mg helps to make blood flow more easily, preventing harmful clots from forming and thereby reducing the risk of life-threatening events.
